FEops Announces 2.000 Patients Modelled With FEops HEARTguide™
Summary
FEops HEARTguide™ is currently commercially available in the European Union, Canada and Australia for its TAVI and LAAo workflows and offers a one-in-its-kind procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology. This significant milestone is reached thanks to the physicians who use our technology on regular basis, our partners who support us in this journey and our highly dedicated team.” said Matthieu De Beule, co-founder and CEO FEops.” In line with FEops’ vision to strive to better patient care, optimize procedure efficiency and reduce costs, FEops will bring additional clinical evidence for its LAAo and TAVI indications in 2021. “Having access to FEops simulations fused with CT contours of patient’s cardiac anatomy and live fluoroscopic images during the procedure is adding significant value. Privately held FEops, headquartered in Gent, Belgium, is a digital health leader in personalized predictive planning for structural heart interventions. In September 2017, FEops announced that it closed a 6 million euros financing, led by Valiance, and joined by existing investors Capricorn Venture Partners and PMV.